logo
Why the dollar's wobble could be self-perpetuating

Why the dollar's wobble could be self-perpetuating

Reuters2 days ago

LONDON, May 29 (Reuters Breakingviews) - Foreign currency hedging is not a topic that usually dominates the water-cooler chats on trading floors. Right now, however, it's front of mind for many of the biggest players in financial markets. The U.S. dollar's unusual moves in April, when it fell in tandem with stocks, has cast doubt over a long-lasting relationship between the greenback and risky assets. Over time, it might nudge non-U.S. investors to hedge more or reduce their exposure to American stocks and bonds. Both could create a self-reinforcing downward cycle for the dollar.
Investing abroad is a tricky business for money managers with liabilities denominated in the currency of their home country. Think German or Japanese insurers, whose policies are written in euros and yen, or Canadian and Australian pension funds, whose beneficiaries expect to finance their retirement in Canadian and Aussie dollars. Buying shares and debt issued by companies in other countries introduces the danger that foreign exchange swings will reduce the value of the investments in local-currency terms, even if the underlying returns are good. That is why investors tend to use foreign exchange forwards and other derivatives to hedge currency risks, effectively swapping far-flung exposures into domestic ones.
The beauty of holding U.S. assets, though, is that the dollar tends to strengthen when the market panics. In money-manager speak, it's an anti-cyclical currency, which means investment bosses can get away with minimal protection against foreign exchange risk on giant portfolios of American stocks and bonds. It also helps that the dollar has generally risen in recent years, providing foreign investors with an extra boost to their overall returns.
One study, opens new tab, published by the National Bureau of Economic Research, found that foreign insurers, pension funds and mutual funds hedged 44%, 35% and 21% of their respective dollar portfolios in 2020, with much higher ratios for bonds compared to stocks. Apply that range to the $30 trillion of total American assets held by non-U.S. investors as of last year, and the implication is that anywhere between $24 trillion and $17 trillion could be unhedged.
Take the Canada Pension Plan Investment Board for example. U.S. dollar exposures account, opens new tab for more than half of its net investments of $520 billion, but are minimally hedged, according to a person familiar with the portfolio. Several people involved in the running of different Canadian retirement funds told Breakingviews that the safe-haven nature of the greenback was a key reason for relatively low hedge ratios. Japan's giant Government Pension Investment Fund, meanwhile, had invested almost a third of its $1.7 trillion portfolio in American assets as of March 2024 with slightly more than half in stocks and the rest in bonds. The U.S. exposure was almost entirely unhedged, a person familiar with the matter told Breakingviews.
According to traders and analysts these large so-called 'open' positions in U.S. assets have caught the attention of currency market players in recent months, for two reasons. First, the dollar didn't live up to its safe-haven billing after U.S. President Donald Trump's tariff plan tanked stocks in early April. The greenback fell roughly 5% against a basket of other rich-world currencies and failed to rebound alongside the S&P 500 Index when trade tensions cooled. The upshot for foreign investors is that volatile U.S. policymaking may cause the dollar to gyrate in the same way as equity markets. If that becomes the norm, foreign investors' risk models would over time call for much more dollar hedging.
The second consideration is that Trump and his advisers seem set on weakening the currency in a bid to boost exports. That is cementing a sense in foreign currency markets that the dollar is unlikely to see another 2022-style surge in strength, meaning overseas investors may be more likely to get a drag from the greenback rather than a lift.
One open question is whether it is even possible for large pension funds and insurers to meaningfully increase the proportion of their dollar portfolios that are hedged. In places where local institutions' holdings of U.S. assets are large relative to the local market, such as Taiwan or Nordic countries like Sweden, a big increase in demand for FX derivatives could meaningfully affect the value of the domestic currency. The Taiwan dollar's recent surge against the greenback looks like a case in point.
Even in deeper markets like the Japanese yen, euro or Canadian dollar, hedging comes at a price. The typical method is to use forward contracts, which involves locking in an exchange rate by agreeing to buy one currency and sell another at a future date. The cost is largely determined by the difference in government bond yields between the two markets. Relatively high U.S. interest rates therefore make it expensive for local investors to hedge their dollar exposure.
One-year contracts currently imply a roughly 2% annual cost for Canadian and European investors and 4% for those in Japan, according to Breakingviews calculations. The implication is that institutions which hedge an extra quarter of their U.S. portfolio could reduce returns by 0.5 percentage points to 1 percentage point, all else being equal. That raises the bar for holding American assets relative to home-country ones.
The alternative to extra hedging is for big institutional investors to shrink their exposure to the U.S., for example by investing the marginal euro, yen or loonie elsewhere. Pension managers and insurers generally take months or years to change their investment policies, meaning any shift won't be immediate. Yet there are signs that both may already be happening in a small way. Traders and investors say the recent slide in the dollar is partly due to extra hedging activity, which mechanically weakens the currency that is being hedged. Meanwhile, non-U.S. participation in a recent 30-year Treasury bond auction was the lowest since 2019, Reuters reported.
The danger, from a dollar holder's perspective, is that these trends reinforce one another. A weaker and more volatile greenback may inflict losses on foreign owners of U.S. assets, inducing them to sell or hedge more, in turn weakening the currency even further. At some point American assets might look cheap enough for global investors to pile back in – but not before the dollar falls further.
Follow @Breakingviews, opens new tab on X

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer

Reuters

time22 minutes ago

  • Reuters

Gilead's CAR-T cell therapy shows promise in deadly brain cancer

CHICAGO, June 1 (Reuters) - A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent glioblastoma, a rare event for a fatal brain cancer with few treatment options, researchers reported on Sunday. The study, presented at the American Society of Clinical Oncology meeting in Chicago and published in Nature Medicine, is the latest among several efforts testing next-generation chimeric antigen receptor T-cell or CAR-T treatments, a type of immunotherapy in which patients' immune cells are engineered to recognize and kill cancer cells. The work, from researchers at the University of Pennsylvania and Gilead's (GILD.O), opens new tab Kite cell therapy unit, tested a dual CAR-T treatment in an effort to overcome the defenses of glioblastoma, the most common brain tumor in adults. CAR-T therapy is already used to treat blood cancers including leukemia, lymphoma and multiple myeloma, and those treatments typically only take aim at one target on the tumor. But solid tumors such as glioblastoma tend to have multiple subpopulations of tumor cells, suggesting that treatments will need more than one target to succeed, said University of Pennsylvania researcher Dr. Stephen Bagley, who led the study. For the treatment, which is injected directly into spinal fluid, the team selected EGFR, which is found in 50% to 60% of all glioblastoma tumors, and a second target called interleukin-13 receptor alpha 2, found in an estimated 75% of glioblastoma tumors. Typically, advanced glioblastoma patients whose cancers return after initial treatment with surgery, radiation and chemotherapy live six to 10 months. Interim results of just six patients were published in March 2024 in Nature Medicine, opens new tab. The current study now includes 18 patients treated with the experimental therapy after their tumors returned following standard treatment. Of these, only 13 had a measurable tumor at the time the cells were introduced, and of those, eight, or 62%, had their tumors shrink, Bagley said. "That was pretty remarkable to us because historically for recurrent glioblastoma tumors, we usually don't see anything shrink them." Several patients lived 12 months or longer, and in one patient, the disease remained stable for 16 months. But so far, the benefit is largely temporary, with many patients relapsing two to three months later. Most patients experienced fevers and neurotoxicity such as lethargy or confusion for two or three days after the cells are injected, but the side effects were manageable, Bagley said. Cindy Perettie, executive vice president of Gilead's Kite cell therapy unit, said she is encouraged by the 62% response. "What we didn't see that we wanted to in a majority of the patients was persistence," she said. Kite is working to develop a third target that will allow the drug to remain in the brain longer. "We will be putting that construct into the clinic sometime next year," she said. Meanwhile, the team wants to test the therapy in 12 patients with newly diagnosed disease. "We know patients in the frontline setting are going to be healthier," she said, and the hope is to see more persistent results. Demand for the trial has been great. Perettie estimates there are 10 times as many patients seeking enrollment for every open slot, and some doctors are referring patients from as far away as Hawaii. "Today, there's only one approved therapy outside of radiation, so for these patients, this is really exciting to see any kind of response," she said. Kite hopes to expand to three or four centers with its triple-target version of the product. "I think we're on the right track," Bagley said, adding that he believes there will be longer-lasting treatments in the next few years.

EXCLUSIVE We hit the jackpot with a life-changing deal on Dragons' Den - here's how much contact we REALLY have with the investors after the show
EXCLUSIVE We hit the jackpot with a life-changing deal on Dragons' Den - here's how much contact we REALLY have with the investors after the show

Daily Mail​

time33 minutes ago

  • Daily Mail​

EXCLUSIVE We hit the jackpot with a life-changing deal on Dragons' Den - here's how much contact we REALLY have with the investors after the show

The co-founders of a pet food brand bagged a life-changing deal on Dragons' Den and have revealed how the show has shaped their business since. Dr Guy Sandelowsky, 38, and Shiv Sivakumar, 33, developed their allergy-friendly pet food business, called Omni, together. The pair appeared on BBC 's long-standing entrepreneur show in February and managed to secure a £75,000 investment from Deborah Meaden, 66, and Steven Bartlett, 32, for a 2.5% share. They impressed the Dragons with their company, which uses novel proteins to create allergy-friendly food for dogs and offers a range of supplements. Now, three months since the episode aired, Guy and Shiv have opened up to MailOnline about their 'nerve wracking' business pitch which landed them a deal with two tycoons. From A-list scandals and red carpet mishaps to exclusive pictures and viral moments, subscribe to the DailyMail's new Showbiz newsletter to stay in the loop. The businessmen admitted 'it wasn't easy to get on' the show and they had applied two years in a row before. 'We were just determined that, you know, the world and the nation needed to hear about what Omni was doing,' Guy explained. The pair created Omni after Shiv, who has a dog prone to allergies and Guy, who has 10 years experience as a vet, came together with the aim to help prevent common problems in pets. Before entering the infamous den, the pair already had their sight set on two of the dragons and knew what they wanted to leave with. 'Shiv and I had watched Dragons' Den forever, since we can remember, and the likes of Deborah Meaden and even Steven Bartlett, even though he's a dragon that joined later on, we always admired them,' Guy revealed. He admitted: 'We always knew that, were we to be on the show, those are exactly the dragons we'd want, not least because they have pets, but also because they're just so aligned with what we're trying to do, creating a health sustainability brand.' The vet described the experience as 'really surreal, honestly and very overwhelming, but in a very positive way'. Despite carefully preparing an impressive business pitch, Shiv shared 'when it comes down to it, it was very sort of nerve wracking, because you realise you're going to go on TV'. He added: 'No matter how much you plan, you just don't know how things are going to play out.' During their business pitch, Shiv and Guy were quickly hit with questions from Peter Jones and Touker Suleyman about their valuations. Shiv admitted they were 'a little surprised' by how fast the conversation went in that direction and pointed out they have now gone above and beyond with their business since. However, the pair did manage to keep their cool during the grilling from the dragons. Shiv said: 'It's really interesting, because we're now, literally a couple of months since being on the den, and the business ... it's doubled in size, we're now tracking revenues for the year of nearly £10 million annualised, which is way more than the valuation we even went into the den asking for.' Eventually, Touker and Peter pulled out of making offers and Sara Davies declined on the basis the share was too low. Despite this, the two businessmen are thrilled about securing Deborah and Steven. Shiv explained how 'well aligned' the business partners are with the two dragons. He added: 'They authentically care about sort of what we're trying to achieve here. So they're both pet lovers. Steven actually has a dog that's prone to allergies as well. Really has an authentic connection to the environment and sustainability too. 'They both are very good ambassadors and advocates for our business, and that's what we hoped they would do, and they've continued to do that as well since the investment. 'So we couldn't have got a better result, because those are the investors that we wanted to achieve. And we did manage to get this. I think we were pretty elated.' Guy recalled how the knew the valuation they were asking for was 'reasonable' and even described it as 'quite generous'. He admitted: 'It just felt very validating when people like Deborah and Steven actually got behind us, and sort of actually on our behalf, were like arguing with Peter and Touker.' Since securing a joint deal with Deborah and Steven, the co-founders have been 'pleasantly surprised' by how involved the dragons have been with Omni since being on the show. Guy acknowledged that even though they are both 'celebrities' and 'very busy' with other projects, in reality 'it doesn't feel like that'. '... The line's always open. We can always speak to them,' he revealed. 'I would say that with Steven and his team, we've had particular guidance and support on some of the brand work that we're doing.' As for Deborah, who is known for her environmentally friendly business pursuits, the Omni co-founders feel particularly 'mission aligned' with her. 'You know, for us, health is number one, but also the fact that we don't use animal proteins in our products, it just makes our food more environmentally sustainable,' Guy explained. 'And I think because that's a mission that's so close to Deborah's heart, it was quite easy to build that connection.' He added: 'Whenever we do meet Deborah and we discuss our business plans, it's clear that she really cares, and she knows that when our business grows, yes, there's financial upside, but also the ethical side is really important to her, and she's helping to grow a business that is going to sort of contribute to practices that are better for the environment as well.'

Defence review is ‘message to Moscow'
Defence review is ‘message to Moscow'

Glasgow Times

time35 minutes ago

  • Glasgow Times

Defence review is ‘message to Moscow'

The Government has pledged £1.5 billion to set up at least six factories, and will support the procurement of up to 7,000 UK-built long-range weapons in response to the strategic defence review (SDR) to be published on Monday. The new funding will see UK munitions spend hit £6 billion during this parliament and support around 1,800 jobs throughout the country. Sir Keir Starmer has called the review a 'radical blueprint' and pledged a 'wave of investments' in shipbuilding, drone technology and cyber defences. Defence Secretary John Healey said the £6 billion of investment would 'equip our forces for the future' and 'create the jobs in every part of the UK'. Sir Keir Starmer and John Healey on board HMS Prince of Wales in Plymouth, ahead of an eight-month deployment to the Indo-Pacific region on Operation Highmast (Richard Pohle/The Times/PA) 'This is a message to Moscow as well. This is Britain standing behind, making our armed forces stronger but making our industrial base stronger, and this is part of our readiness to fight, if required,' he told the BBC's Sunday Morning With Laura Kuenssberg programme. He said Russia is 'attacking the UK daily' as part of some 90,000 cyber attacks from state-linked sources were directed at the UK's defence over the last two years. A cyber command to counter such threats is being set up as part of the review. Asked if he expected a form of real-world attack by Russia on the UK in the coming years, he said: 'We have to be prepared. Nato has to be prepared. We see Putin in Ukraine trying to redraw international boundaries by force … it's part of the growing Russian aggression.' He added that is why Nato and the UK are 'stepping up our ability to deter as well as to defend in the future'. 'The world is more uncertain. The tensions are greater but we prepare for war in order to secure the peace. If you're strong enough to defeat an enemy you deter them from attacking in the first place,' Mr Healey said. He said plans to reach 2.5% of GDP spending on defence by 2027 and an 'ambition' to hit 3% in the next parliament were 'enough to deliver the SDR's vision that sets out tomorrow, and that vision is a transformation of Britain's armed forces.' He said there was 'no doubt' the Government would reach 3% in the next parliament. But he said he does not expect to make progress towards raising the number of soldiers to 73,000 until the next parliament. 'We've narrowed the gap, but we've still got more people leaving than joining. 'The first job is to reverse that trend and then I want to see in the next parliament our ability to start to increase the number,' he said. Defence minister Alistair Cairns, writing in The Mirror, said there were plans to increase cadet numbers by 30% with new opportunities for young people to get into the armed forces. And more than £1.5 billion in extra funding will go to military homes for urgent repairs such as fixing boilers and roofs, and other issues including tackling damp. Shadow justice secretary Robert Jenrick welcomed the Government's pledge to increase defence spending but said he was 'sceptical' as to whether the Chancellor would make good on the plans. Mr Jenrick said the UK should reach 3% of GDP spending on defence 'within this parliament'. 'We think that 2034 is a long time to wait given the gravity of the situation,' he told the Sunday Morning With Trevor Phillips programme on Sky News.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store